Business Description
Ocean Biomedical Inc
NAICS : 541714
SIC : 2834
ISIN : US67644C1045
Description
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ocean Biomedical Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.829 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | - | ||
| 20-Day SMA (€) | 0.012 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 0.012 - 0.012 | ||
| Shares Outstanding (Mil) | 232.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ocean Biomedical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ocean Biomedical Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-30 | In 114 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 6 days | ||
| First quarter earnings results for 2026 | 2026-08-12 | In 4 days | ||
| General meeting for 2025 | 2026-08-12 | In 4 days | ||
| Annual report for 2025 | 2026-08-05 | 0.01 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-05-15 | 0.01 (+0.00%) | ||
| Annual report for 2024 | 2025-04-08 | 0.04 (+5.19%) | ||
| General meeting for 2024 | 2025-03-28 09:00 | 0.06 (-21.34%) | ||
| Third quarter earnings results for 2024 | 2025-01-13 | 0.62 (-2.36%) | ||
| First quarter earnings results for 2024 | 2024-12-23 | 0.53 (-3.64%) |
Show
Entries
Ocean Biomedical Inc Frequently Asked Questions
What is Ocean Biomedical Inc(FRA:8AW0)'s stock price today?
The current price of FRA:8AW0 is €0.01. The 52 week high of FRA:8AW0 is €0.01 and 52 week low is €0.01.
When is next earnings date of Ocean Biomedical Inc(FRA:8AW0)?
The next earnings date of Ocean Biomedical Inc(FRA:8AW0) is 2026-08-12 Est..
Does Ocean Biomedical Inc(FRA:8AW0) pay dividends? If so, how much?
Ocean Biomedical Inc(FRA:8AW0) does not pay dividend.
Press Release
Articles on Ocean Biomedical Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers